Trial Profile
A randomized controlled trial by a parallel group design in a single institution to evaluate the effectiveness of oral adjuvant chemotherapy using uracil-tegafur to prevent recurrence after curative resection of hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Aug 2012
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary)
- Indications Liver cancer
- Focus Therapeutic Use